A subclass of peptide hydrolases that depend on a CYSTEINE residue for their activity.
https://www.ema.europa.eu/en/medicines/human/EPAR/idefirix 2020 false false false United Kingdom French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation drug approval europe imlifidase orphan drug production graft rejection infusions, intravenous adult kidney transplantation product surveillance, postmarketing histocompatibility aged drug interactions pregnancy breast feeding cysteine proteases cysteine proteases drug evaluation, preclinical Imlifidase Imlifidase